Mediclinic International Plc

Public consensus   -   Last updated 08/10/20

Reporting currency: GBP
Reporting unit: Absolute
 
NO. OF
FORECASTS
FY22
CONSENSUS
08/10/20
FY22
MIN
FY22
MAX
Hirslanden (CHF'm) - Adjusted
Revenue
7
1,841
1,750
1,935
EBITDA
7
309
293
324
EBITDA margin (%)
7
16.8
16.2
17.6
Average FX rate GBP/CHF
7
1.21
1.17
1.25
Southern Africa (ZAR'm) - Adjusted
Revenue
7
17,829
16,377
18,638
EBITDA
7
3,527
2,904
3,699
EBITDA margin (%)
7
19.8
17.7
20.5
Average FX rate GBP/ZAR
7
21.80
21.00
23.32
Middle East (AED'm) - Adjusted
Revenue
7
3,678
3,409
4,033
EBITDA
7
585
520
658
EBITDA margin (%)
7
15.9
14.7
16.4
Average FX rate GBP/AED
7
4.69
4.59
4.79
Adjusted Group (GBP'm)
Revenue
7
3,126
2,895
3,354
EBITDA
7
541
476
580
EBITDA margin (%)
7
17.3
16.4
17.9
Operating profit
7
319
267
352
Earnings per share (pence)
7
24.2
20.2
27.2
Dividend per share (pence)
6
6.2
2.0
8.3
Net Debt
6
1,959
1,565
2,098
Net cash generated from operating activities
6
374
218
417
Total Group Capex
7
207
184
240

Disclaimer

Mediclinic International plc (“Mediclinic”) does not endorse or adopt any of the consensus estimates expressed in this report. The report represents the views of analysts from which the consensus estimates are derived. Mediclinic will not provide any commentary on the consensus or answer questions on it. The circulation of the consensus by Mediclinic is not mandatory and Mediclinic may amend its practice on this at any time.